The total return over the past 12 months is +37.29% vs. +16.94% for the S&P 500. So far it's up +34.35% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +37.29% | (4.01%) | (13.62%) | (13.11%) | (1.01%) | N/A |
| Total Return CAGR | +37.29% | (4.01%) | (13.62%) | (13.11%) | (1.01%) | N/A |
| Revenue CAGR | +583.87% | N/A | (25.46%) | N/A | N/A | (0.56%) |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
MediciNova, Inc. (MNOV)
| Year | Start price | End price | MNOV Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.31 | $1.76 | +34.35% | +14.51% | +19.84% |
| 2025 | $2.10 | $1.31 | (37.62%) | +17.72% | (55.34%) |
| 2024 | $1.50 | $2.10 | +40.00% | +24.89% | +15.11% |
| 2023 | $2.05 | $1.50 | (26.83%) | +26.19% | (53.02%) |
| 2022 | $2.68 | $2.05 | (23.51%) | (18.17%) | (5.34%) |
| 2021 | $5.26 | $2.68 | (49.05%) | +28.74% | (77.79%) |
| 2020 | $6.74 | $5.26 | (21.96%) | +18.37% | (40.33%) |
| 2019 | $8.17 | $6.74 | (17.50%) | +31.22% | (48.72%) |
| 2018 | $6.47 | $8.17 | +26.28% | (4.56%) | +30.84% |
| 2017 | $6.03 | $6.47 | +7.30% | +21.70% | (14.40%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
